Wells Fargo’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$294K Buy
84,980
+9,466
+13% +$32.8K ﹤0.01% 4136
2025
Q1
$198K Buy
75,514
+4,089
+6% +$10.7K ﹤0.01% 4270
2024
Q4
$294K Sell
71,425
-59,042
-45% -$243K ﹤0.01% 4066
2024
Q3
$924K Buy
130,467
+86,662
+198% +$614K ﹤0.01% 3251
2024
Q2
$286K Buy
43,805
+10,274
+31% +$67K ﹤0.01% 3920
2024
Q1
$278K Buy
33,531
+5,682
+20% +$47.2K ﹤0.01% 3906
2023
Q4
$307K Sell
27,849
-63,741
-70% -$702K ﹤0.01% 3835
2023
Q3
$770K Sell
91,590
-49,651
-35% -$418K ﹤0.01% 3248
2023
Q2
$1.77M Buy
141,241
+51,516
+57% +$647K ﹤0.01% 2860
2023
Q1
$1.48M Buy
89,725
+88,819
+9,803% +$1.46M ﹤0.01% 2922
2022
Q4
$13.5K Sell
906
-1,727
-66% -$25.8K ﹤0.01% 5103
2022
Q3
$59K Sell
2,633
-748
-22% -$16.8K ﹤0.01% 4575
2022
Q2
$56K Sell
3,381
-20,713
-86% -$343K ﹤0.01% 4702
2022
Q1
$721K Sell
24,094
-22,726
-49% -$680K ﹤0.01% 3892
2021
Q4
$1.44M Sell
46,820
-3,646
-7% -$112K ﹤0.01% 3570
2021
Q3
$1.59M Buy
50,466
+19,867
+65% +$627K ﹤0.01% 3671
2021
Q2
$1.12M Buy
30,599
+20,779
+212% +$761K ﹤0.01% 3914
2021
Q1
$340K Sell
9,820
-13,386
-58% -$463K ﹤0.01% 4591
2020
Q4
$964K Sell
23,206
-9,810
-30% -$408K ﹤0.01% 3993
2020
Q3
$1.41M Buy
+33,016
New +$1.41M ﹤0.01% 3538